IL233875A - Composition and use thereof in the treatment of anal rhagades - Google Patents

Composition and use thereof in the treatment of anal rhagades

Info

Publication number
IL233875A
IL233875A IL233875A IL23387514A IL233875A IL 233875 A IL233875 A IL 233875A IL 233875 A IL233875 A IL 233875A IL 23387514 A IL23387514 A IL 23387514A IL 233875 A IL233875 A IL 233875A
Authority
IL
Israel
Prior art keywords
preparation
treatment
anal fissures
fissures
anal
Prior art date
Application number
IL233875A
Other languages
English (en)
Hebrew (he)
Other versions
IL233875A0 (en
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL233875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of IL233875A0 publication Critical patent/IL233875A0/en
Publication of IL233875A publication Critical patent/IL233875A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • A61K36/5775Hibiscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL233875A 2012-01-30 2014-07-30 Composition and use thereof in the treatment of anal rhagades IL233875A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (2)

Publication Number Publication Date
IL233875A0 IL233875A0 (en) 2014-09-30
IL233875A true IL233875A (en) 2017-01-31

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233875A IL233875A (en) 2012-01-30 2014-07-30 Composition and use thereof in the treatment of anal rhagades

Country Status (23)

Country Link
US (1) US9345747B2 (cg-RX-API-DMAC7.html)
EP (1) EP2646039B1 (cg-RX-API-DMAC7.html)
JP (1) JP5903505B2 (cg-RX-API-DMAC7.html)
KR (1) KR101599447B1 (cg-RX-API-DMAC7.html)
CN (2) CN109865000A (cg-RX-API-DMAC7.html)
AU (1) AU2012368815B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014018850A8 (cg-RX-API-DMAC7.html)
CA (1) CA2863369C (cg-RX-API-DMAC7.html)
DK (1) DK2646039T3 (cg-RX-API-DMAC7.html)
ES (1) ES2485490T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140594T1 (cg-RX-API-DMAC7.html)
IL (1) IL233875A (cg-RX-API-DMAC7.html)
IN (1) IN2014MN01733A (cg-RX-API-DMAC7.html)
MX (1) MX336204B (cg-RX-API-DMAC7.html)
PL (1) PL2646039T3 (cg-RX-API-DMAC7.html)
RS (1) RS53457B (cg-RX-API-DMAC7.html)
RU (1) RU2580622C2 (cg-RX-API-DMAC7.html)
SA (1) SA113340239B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201404413UA (cg-RX-API-DMAC7.html)
SI (1) SI2646039T1 (cg-RX-API-DMAC7.html)
TW (1) TWI495476B (cg-RX-API-DMAC7.html)
WO (1) WO2013114410A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201405208B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2932156A1 (en) 2013-12-24 2015-07-02 The Procter & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
ATE214266T1 (de) * 1997-04-16 2002-03-15 Cognis France Sa Verwendung einer aus hibiskus-esculentus-samen extrahierten proteinfraktion in der kosmetik
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
EP1622627B1 (en) * 2003-05-02 2013-05-22 Ceapro Inc. Pharmaceutical compositions comprising cereal beta(1-3) beta(1-4) glucan
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
EP2646039B1 (en) 2014-05-14
DK2646039T3 (da) 2014-08-11
TWI495476B (zh) 2015-08-11
BR112014018850A8 (pt) 2017-07-11
IL233875A0 (en) 2014-09-30
MX2014009244A (es) 2015-03-19
RU2580622C2 (ru) 2016-04-10
JP2015504915A (ja) 2015-02-16
ES2485490T3 (es) 2014-08-13
JP5903505B2 (ja) 2016-04-13
SG11201404413UA (en) 2014-10-30
IN2014MN01733A (cg-RX-API-DMAC7.html) 2015-07-10
AU2012368815A1 (en) 2014-09-18
CN109865000A (zh) 2019-06-11
KR20140127296A (ko) 2014-11-03
WO2013114410A1 (en) 2013-08-08
SI2646039T1 (sl) 2014-10-30
HK1186378A1 (en) 2014-03-14
RU2014129391A (ru) 2016-03-27
TW201334787A (zh) 2013-09-01
AU2012368815B2 (en) 2018-03-01
CN104114177A (zh) 2014-10-22
EP2646039A1 (en) 2013-10-09
MX336204B (es) 2016-01-11
KR101599447B1 (ko) 2016-03-14
SA113340239B1 (ar) 2015-07-07
BR112014018850A2 (cg-RX-API-DMAC7.html) 2017-06-20
CA2863369C (en) 2020-03-10
US9345747B2 (en) 2016-05-24
RS53457B (sr) 2014-12-31
ZA201405208B (en) 2015-10-28
PL2646039T3 (pl) 2014-10-31
CA2863369A1 (en) 2013-08-08
HRP20140594T1 (hr) 2014-10-24
US20140303094A1 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
TWI560180B (en) Substituted benzamides and methods of use thereof
CL2015000640A1 (es) Variantes de hppd y métodos de uso
HUE046292T2 (hu) Melanóma kezelése és diagnosztizálása
IL235512B (en) Phenylbenzamide derivatives for use in treating diseases mediated by aquaporin
IL235401A0 (en) St2l antagonists and methods of use
HUE039997T2 (hu) Szulfamoilpirrolamid származékok és alkalmazásuk hepatitisz B kezelésére szolgáló gyógyszerekként
HUE040446T2 (hu) Szulfamoiltiofenamid-származékok és gyógyszerként történõ alkalmazásuk hepatitis B kezelésére
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
LT2885010T (lt) Tautopatijos gydymo būdai
HUE040111T2 (hu) Vegyületek és alkalmazási eljárásaik
GB201320729D0 (en) Therapeutic compounds and their use
BR112014009634A2 (pt) preparação e agente terapêutico
IL237592B (en) Methods of expanding and assessing b cells and using expanded b cells to treat disease
BR112015001712A2 (pt) uso de s-pindolol para o tratamento da caquexia e sarcopenia
HRP20182046T1 (hr) Uređaj za kuhanje i postupak njegove upotrebe
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
FI20135537L (fi) Saostumanestoseos ja sen käyttö
LT2928477T (lt) Telomerazės inhibitoriaus imetelstato panaudojimas mielofibrozės gydymui
PL2922576T3 (pl) Sposoby podawania i oceny leków wychwytujących azot do leczenia encefalopati wątrobowej
GB201311361D0 (en) Compounds and their therapeutic use
IL235968B (en) Polysaccharide compositions and methods of use
IL234606B (en) Novel methods and composition for treatment of disease
HUE040496T2 (hu) Vegyületek elhízás kezelésére és alkalmazási eljárásaik
IL233875A (en) Composition and use thereof in the treatment of anal rhagades
IL235909A0 (en) Heteroaryl compounds and methods of use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed